[{"address1": "301 Binney Street", "address2": "3rd Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 259 3860", "website": "https://www.scholarrock.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGF\u00df) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 128, "companyOfficers": [{"maxAge": 1, "name": "Mr. David L. Hallal", "age": 58, "title": "CEO & Chairman of the Board", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 175732, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mo  Qatanani Ph.D.", "age": 51, "title": "Chief Scientific Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 704681, "exercisedValue": 0, "unexercisedValue": 3032789}, {"maxAge": 1, "name": "Dr. Akshay K. Vaishnaw M.D., Ph.D.", "age": 61, "title": "President of R&D, Member of Scientific Advisory Board and Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 56140, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jing L. Marantz M.B.A., M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 755185, "exercisedValue": 0, "unexercisedValue": 673489}, {"maxAge": 1, "name": "Mr. Vikas  Sinha C.A., CPA, M.B.A.", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Keith Woods", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin  Moore CPA", "age": 49, "title": "Interim Principal Financial & Accounting Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rushmie  Nofsinger", "title": "Vice President of Corporate Affairs & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Junlin  Ho J.D.", "age": 45, "title": "General Counsel & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 563729, "exercisedValue": 0, "unexercisedValue": 112564}, {"maxAge": 1, "name": "Ms. Caryn  Parlavecchio", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 30.07, "open": 34.7554, "dayLow": 34.25, "dayHigh": 39.5, "regularMarketPreviousClose": 30.07, "regularMarketOpen": 34.7554, "regularMarketDayLow": 34.25, "regularMarketDayHigh": 39.5, "payoutRatio": 0.0, "forwardPE": -17.4, "volume": 6965287, "regularMarketVolume": 6965287, "averageVolume": 2600240, "averageVolume10days": 2072680, "averageDailyVolume10Day": 2072680, "bid": 37.21, "ask": 37.56, "bidSize": 5, "askSize": 1, "marketCap": 3596120832, "fiftyTwoWeekLow": 22.71, "fiftyTwoWeekHigh": 46.98, "allTimeHigh": 70.0, "allTimeLow": 4.325, "fiftyDayAverage": 32.4487, "twoHundredDayAverage": 33.6458, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3556545024, "profitMargins": 0.0, "floatShares": 85036476, "sharesOutstanding": 96127265, "sharesShort": 17901453, "sharesShortPriorMonth": 16419558, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.18620001, "heldPercentInsiders": 0.03987, "heldPercentInstitutions": 1.26316, "shortRatio": 5.92, "shortPercentOfFloat": 0.32619998, "impliedSharesOutstanding": 96127265, "bookValue": 2.47, "priceToBook": 15.145749, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -353428000, "trailingEps": -2.92, "forwardEps": -2.15, "enterpriseToEbitda": -9.866, "52WeekChange": 0.4181198, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 37.41, "targetHighPrice": 53.0, "targetLowPrice": 43.0, "targetMeanPrice": 47.09091, "targetMedianPrice": 46.0, "recommendationMean": 1.23077, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 369630016, "totalCashPerShare": 3.624, "ebitda": -360478016, "totalDebt": 110076000, "quickRatio": 5.964, "currentRatio": 6.305, "debtToEquity": 44.93, "returnOnAssets": -0.76607, "returnOnEquity": -2.18037, "grossProfits": -184550000, "freeCashflow": -175936368, "operatingCashflow": -274052000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SRRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 24.4097, "regularMarketPrice": 37.41, "marketState": "CLOSED", "shortName": "Scholar Rock Holding Corporatio", "longName": "Scholar Rock Holding Corporation", "postMarketChangePercent": -0.3475035, "postMarketPrice": 37.28, "postMarketChange": -0.13000107, "regularMarketChange": 7.34, "regularMarketDayRange": "34.25 - 39.5", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2600240, "fiftyTwoWeekLowChange": 14.700001, "fiftyTwoWeekLowChangePercent": 0.647292, "fiftyTwoWeekRange": "22.71 - 46.98", "fiftyTwoWeekHighChange": -9.57, "fiftyTwoWeekHighChangePercent": -0.2037037, "fiftyTwoWeekChangePercent": 41.811977, "earningsTimestamp": 1763127000, "earningsTimestampStart": 1763127000, "earningsTimestampEnd": 1763127000, "earningsCallTimestampStart": 1763125200, "earningsCallTimestampEnd": 1763125200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.92, "epsForward": -2.15, "epsCurrentYear": -3.4685, "priceEpsCurrentYear": -10.785643, "fiftyDayAverageChange": 4.9613, "fiftyDayAverageChangePercent": 0.15289672, "twoHundredDayAverageChange": 3.7641983, "twoHundredDayAverageChangePercent": 0.11187721, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1527255000000, "exchange": "NMS", "messageBoardId": "finmb_548810128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1763168393, "regularMarketTime": 1763154000, "displayName": "Scholar Rock Holding", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]